World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
41661
World Ranking
12007
National Ranking
35

Wee Joo Chng publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Wee Joo Chng sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 735 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Wee Joo Chng D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Wee Joo Chng sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Wee Joo Chng is affiliated with the National University of Singapore in Singapore. Their research spans significant contributions within the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on subfields such as Molecular Biology, Hematology, Oncology, Pathology and Forensic Medicine, and Genetics.

The scientist's work addresses critical topics including:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Peptidase Inhibition and Analysis
  • Lymphoma Diagnosis and Treatment
  • RNA modifications and cancer
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research

Wee Joo Chng has frequently published in key venues within hematological and oncological research, such as:

  • Blood
  • Cancer Research
  • Clinical Lymphoma Myeloma & Leukemia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood Cancer Journal

Some of their recent papers reflect developments in classification and treatment strategies in hematolymphoid tumors, as well as enabling technologies for precision medicine. Notable publications include:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms (2022, Leukemia)
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (2022, Leukemia)
  • Enabling Technologies for Personalized and Precision Medicine (2020, Trends in biotechnology)
  • Identification of differential RNA modifications from nanopore direct RNA sequencing with xPore (2021, Nature Biotechnology)
  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group (2021, The Lancet Oncology)

The scientist has established frequent collaborations with other researchers including Sanjay De Mel, Melissa Ooi, Cinnie Yentia Soekojo, Anand D. Jeyasekharan, and Chandramouli Nagarajan, reflecting a network of coauthors contributing to fields related to hematology and oncology.

Best Publications

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

    Jonathan J. Keats;Rafael Fonseca;Marta Chesi;Roelandt Schop

  • Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

    Meletios Athanasios Dimopoulos;Philippe Moreau;Antonio Palumbo;Douglas Edgar Joshua

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

  • Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    Pieter Sonneveld;Hervé Avet-Loiseau;Sagar Lonial;Saad Usmani

  • A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.

    King Pan Ng;Axel M Hillmer;Charles T H Chuah;Charles T H Chuah;Wen Chun Juan

  • IMWG consensus on risk stratification in multiple myeloma

    W J Chng;A Dispenzieri;C-S Chim;R Fonseca

  • Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

    George Mulligan;Constantine Mitsiades;Barb Bryant;Fenghuang Zhan

  • Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

    Michele Cavo;Evangelos Terpos;Cristina Nanni;Philippe Moreau

  • Genetic aberrations and survival in plasma cell leukemia.

    R E Tiedemann;N Gonzalez-Paz;R A Kyle;R Santana-Davila

  • AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies

    Marta Chesi;Davide F. Robbiani;Michael Sebag;Wee Joo Chng

  • Telomerase directly regulates NF-κB-dependent transcription

    Arkasubhra Ghosh;Gaye Saginc;Shi Chi Leow;Ekta Khattar

  • Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial

    Meletios A. Dimopoulos;Hartmut Goldschmidt;Ruben Niesvizky;Douglas Joshua

  • P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.

    Xiao-Lan Li;Jianbiao Zhou;Zhi-Rong Chen;Wee-Joo Chng

  • A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

    Seok Jin Kim;Dok Hyun Yoon;Arnaud Jaccard;Wee Joo Chng

  • Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

    Wee J. Chng;Shaji Kumar;Scott VanWier;Greg Ahmann

  • Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    S. K. Kumar;M. A. Dimopoulos;E. Kastritis;E. Terpos

  • Management of treatment-emergent peripheral neuropathy in multiple myeloma

    P G Richardson;Michel Delforge;M Beksac;P Wen

  • Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

    WJ Chng;GF Huang;TH Chung;SB Ng

  • New Drugs and Novel Mechanisms of Action in Multiple Myeloma in 2013: A Report From the International Myeloma Working Group (IMWG)

    E. M. Ocio;P. G. Richardson;S. V. Rajkumar;A. Palumbo

Frequent Co-Authors

Rafael Fonseca
Rafael Fonseca Mayo Clinic
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Shaji Kumar
Shaji Kumar Mayo Clinic
Morie A. Gertz
Morie A. Gertz Mayo Clinic
Brian G.M. Durie
Brian G.M. Durie Cedars-Sinai Medical Center
Philip R. Greipp
Philip R. Greipp Mayo Clinic
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Robert A. Kyle
Robert A. Kyle Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn’t always mean following the traditional MD route. Many students choose alternative online degrees that offer flexibility, affordability, and direct entry opportunities into the healthcare industry. For registered nurses looking to advance their qualifications, affordable rn to bsn programs can be a smart option, helping RNs earn their bachelor’s degree while working.

Those with a non-nursing background may consider entry level msn programs online, which provide a direct pathway to a master’s in nursing without the need for a prior nursing degree. Similarly, students searching for accessible admissions can explore direct entry nursing programs that typically have less competitive requirements and help accelerate entry into the profession.

Not all medical careers require years of clinical training. Many are drawn to healthcare support roles such as medical billing and coding. Fully online programs make it easier to get started, especially through online medical billing and coding schools that accept fafsa, which may reduce financial barriers with federal aid.

Best Scientists Citing Wee Joo Chng

Trending Scientists

Recently Published Articles